Erste Asset Management
MDGL icon

Erste Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Erste Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$51.1M Sell
100,210
-10,000
-9% -$5.28M 0.37% 51
2026
Q2 		$58.1M Sell
110,210
-50,000
-31% -$25.6M 0.45% 47
2026
Q1 		$81M Buy
160,210
+19,110
+14% +$9.13M 0.75% 28
2025
Q4 		$82.3M Sell
141,100
-60,000
-30% -$30.6M 0.69% 32
2025
Q3 		$89.1M Hold
201,100
– – 0.86% 20
2025
Q2 		$60.8M Buy
201,100
+36,700
+22% +$10.9M 0.51% 42
2025
Q1 		$54.4M Hold
164,400
– – 0.7% 37
2024
Q4 		$51.3M Sell
164,400
-70,000
-30% -$19.7M 0.63% 40
2024
Q3 		$49.7M Sell
234,400
-10,980
-4% -$2.81M 0.6% 44
2024
Q2 		$68.9M Sell
245,380
-5,245
-2% -$1.25M 0.91% 25
2024
Q1 		$66.6M Sell
250,625
-74,375
-23% -$17.5M 0.91% 25
2023
Q4 		$75.3M Buy
325,000
+74,600
+30% +$13.1M 1.1% 13
2023
Q3 		$36.7M Buy
250,400
+239,400
+2,176% +$45.1M 0.63% 48
2023
Q2 		$2.42M Hold
11,000
– – 0.04% 265
2023
Q1 		$2.58M Hold
11,000
– – 0.05% 270
2022
Q4 		$3.26M Buy
+11,000
New +$1.08M 0.07% 244

Other funds holding MDGL

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Erste Asset Management's MDGL Position: Q3 2026 in Review

Erste Asset Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 9.1% in Q3 2026, selling an estimated $5.28M and leaving 100,210 shares worth $51.1M. The position accounts for 0.37% of the portfolio, ranked #51.

Erste Asset Management first reported a position in MDGL in Q4 2022 and has held it in 16 quarters since. The position peaked at $89.1M in Q3 2025. 244 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Erste Asset Management held 100,210 shares of Madrigal Pharmaceuticals worth $51.1M as of Q3 2026.
  • Erste Asset Management sold 10,000 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $5.28M.
  • Madrigal Pharmaceuticals made up 0.37% of Erste Asset Management's portfolio in Q3 2026, its #51 holding.
  • Erste Asset Management first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • Erste Asset Management's Madrigal Pharmaceuticals position peaked at $89.1M in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Erste Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.